INSYS Therapeutics Inc. (INSY)

0.30
0.01 4.52
OTC : Health Technology
Prev Close 0.29
Open 0.28
Day Low/High 0.28 / 0.32
52 Wk Low/High 0.14 / 11.65
Volume 1.09M
Avg Volume 3.70M
Exchange OTC
Shares Outstanding 74.57M
Market Cap 21.71M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of April 15th Options Trading For Insys Therapeutics (INSY)

First Week of April 15th Options Trading For Insys Therapeutics (INSY)

Investors in Insys Therapeutics Inc saw new options begin trading this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INSY options chain for the new April 15th contracts and identified one put and one call contract of particular interest.

INSY INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Insys Therapeutics, Inc.

INSY INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Insys Therapeutics, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CAG, CCBG, CREE, ESRT, MLNX, MPX, PDCO, TMUS, VSAT, WMT Downgrades: BKU, FFIN, INSY, IPXL, LM, MGLN, MRC, THC Initiations: ONDK, VLRS Read on to get TheStreet Quant Ratings' detailed report:

STOCK NOTICE: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors Of Important Deadline In Class Action - INSY

STOCK NOTICE: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors Of Important Deadline In Class Action - INSY

Rosen Law Firm, a global investor rights law firm, reminds purchasers of INSYS Therapeutics, Inc.

Insys Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Insys Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

INSYS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Insys Therapeutics, Inc.

INSYS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Insys Therapeutics, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of investors who purchased or otherwise acquired the common stock of Insys Therapeutics, Inc.

Insys Therapeutics (INSY) Highlighted As Weak On High Volume

Insys Therapeutics (INSY) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a weak on high relative volume candidate

The Naughty List: Finalists for Worst Biopharma CEO of 2015

The Naughty List: Finalists for Worst Biopharma CEO of 2015

These five candidates for Worst Biopharma CEO of 2015 have bathed in the muck of mediocrity long enough to warrant your scorn.

3 Stocks the Market Hates But Analysts Love

3 Stocks the Market Hates But Analysts Love

Don't be a lemming! The investment herd is punishing these three stocks, but a rational analysis shows that they're all undervalued growth opportunities for 2016.

Stock To Watch: Insys Therapeutics (INSY) In Perilous Reversal

Stock To Watch: Insys Therapeutics (INSY) In Perilous Reversal

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

Insys Therapeutics (INSY) Is Today's Dead Cat Bounce Stock

Insys Therapeutics (INSY) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "dead cat bounce" (down big yesterday but up big today) candidate

Insys Therapeutics, Inc. Announces Speakers For December 3, 2015 Investor Day

Insys Therapeutics, Inc. Announces Speakers For December 3, 2015 Investor Day

Live Webcast to Begin at 8:30 a.m. EST

Diplomat Seen As Compelling Amid Specialty Pharmacy Fallout

Diplomat Seen As Compelling Amid Specialty Pharmacy Fallout

Shares of Diplomat Pharmacy and pharmacy benefit manager Express Scripts have each been knocked down by the negative news surrounding the sector amid the troubles faced by Valeant and others...

Insys Therapeutics (INSY) Is Today's Dead Cat Bounce Stock

Insys Therapeutics (INSY) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "dead cat bounce" (down big yesterday but up big today) candidate